In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 49 (22) , 1593-1601
- https://doi.org/10.1016/0024-3205(91)90053-e
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationLife Sciences, 1991
- Distribution of somatostatin receptors in normal and tumor tissueMetabolism, 1990
- LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATINThe Lancet, 1989
- Absence of Somatostatin Receptors in Human Exocrine Pancreatic AdenocarcinomasGastroenterology, 1988
- Hormone-Producing Gastrointestinal Tumors Contain a High Density of Somatostatin ReceptorsJournal of Clinical Endocrinology & Metabolism, 1987
- Somatostatin receptors in the adrenalMolecular and Cellular Endocrinology, 1986
- Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitaryNeuroscience, 1985